Chimeric Therapeutics Ltd. 2022 SR
The report outlines Chimeric Therapeutics' commitment to ESG principles, specifically aligning with the World Economic Forum's Stakeholder Capitalism Metrics. It covers governance structures, ethical behavior, and diversity policies while noting that certain environmental metrics like GHG emissions are currently deemed non-material due to the company's small operational footprint. The company utilizes the Socialsuite ESG Go platform to track and report its progress. During the reporting period, the company maintained a small team of nine employees and reported zero workplace fatalities.
Company: Chimeric Therapeutics Ltd.
Sector: Professional & technical services
Country: Australia
Year: 2022
Type: SR
Pages: 8
Back to company
Chimeric Therapeutics Ltd.
ESG Report
The report outlines Chimeric Therapeutics' commitment to ESG principles, specifically aligning with the World Economic Forum's Stakeholder Capitalism Metrics. It covers governance structures, ethical behavior, and diversity policies while noting that certain environmental metrics like GHG emissions are currently deemed non-material due to the company's small operational footprint. The company utilizes the Socialsuite ESG Go platform to track and report its progress. During the reporting period, the company maintained a small team of nine employees and reported zero workplace fatalities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Workplace Fatalities
Employees